Single- and repeated-dose toxicity study of bevacizumab, ranibizumab, and aflibercept in ARPE-19 cells under normal and oxidative stress conditions.

Authors:
Patricia Fernandez-Robredo
Patricia Fernandez-Robredo
Experimental Ophthalmology Laboratory
Spain
Maria Hernandez
Maria Hernandez
University of Southern California
Jaione Bezunartea
Jaione Bezunartea
University of Navarra
Spain
Nicholas Reiter
Nicholas Reiter
University of Wisconsin-Madison
Madison | United States
Sergio Recalde
Sergio Recalde
University of Navarra
Spain

Biochem Pharmacol 2016 Mar 12;103:129-39. Epub 2016 Jan 12.

Experimental Ophthalmology Laboratory, School of Medicine, University of Navarra, 1 Irunlarrea Street, 31008 Pamplona, Spain; Department of Ophthalmology, Clínica Universidad de Navarra, School of Medicine, University of Navarra, 36 Pio XII Avenue, 31008 Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.

We assessed the effect of single and repeated doses of bevacizumab, ranibizumab, and aflibercept on cell viability, proliferation, permeability, and apoptosis of ARPE-19 cells. MTT and BrdU assays were used to determine viability and proliferation after single or repeated doses of anti-VEGF drugs under normal and oxidative stress conditions. Caspase-3 expression after single and repeated doses of the 3 drugs was assessed using immunofluorescence. Transepithelial-electrical-resistance (TER) was measured to study the effect of anti-VEGFs on retinal pigment epithelium (RPE) permeability under normal and oxidative stress conditions. Flow cytometry was used to detect intracellular accumulation of the drugs. Finally, a wound healing assay was performed to investigate the effect of the drugs on RPE cell migration. Single and multiple doses of anti-VEGF drugs had no effect on cell viability and proliferation. The oxidative effect of H2O2 decreased cell viability and proliferation; however, no difference was observed between anti-VEGF treatments. Immunofluorescence performed after single and repeated doses of the drugs revealed some caspase-3 expression. Interestingly, anti-VEGFs restored the increased permeability induced by H2O2. The 3 drugs accumulated inside the cells and were detectable 5 days after treatment. Finally, none of the drugs affected migration. In conclusion, no measureable toxic effect was observed after single or repeated doses of VEGF antagonists under normal and oxidative stress. Intracellular accumulation of the drugs does not seem to be toxic or affect cell functions. Our study suggests that anti-VEGFs could have a preventive effect on the maintenance of the RPE barrier under oxidative stress.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcp.2015.12.017DOI Listing
March 2016
132 Reads

Publication Analysis

Top Keywords

oxidative stress
20
single repeated
20
repeated doses
20
normal oxidative
16
viability proliferation
16
stress conditions
12
cell viability
12
drugs
9
caspase-3 expression
8
doses anti-vegf
8
intracellular accumulation
8
accumulation drugs
8
anti-vegf drugs
8
arpe-19 cells
8
doses drugs
8
ranibizumab aflibercept
8
bevacizumab ranibizumab
8
single
6
doses
6
oxidative
6

Similar Publications